Cargando…
Carbohydrate antigen 19-9 as a novel prognostic biomarker in distal cholangiocarcinoma
BACKGROUND: Distal cholangiocarcinoma (DCC) presents as one of the relatively rare malignant tumors in the digestive system and has a poor long-term prognosis. Curative resection is currently the most appropriate therapy for patients with DCC because of the lack of effective adjuvant therapies. Ther...
Autores principales: | Jiang, Tao, Lyu, Shao-Cheng, Zhou, Lin, Wang, Jing, Li, Han, He, Qiang, Lang, Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462080/ https://www.ncbi.nlm.nih.gov/pubmed/34621478 http://dx.doi.org/10.4240/wjgs.v13.i9.1025 |
Ejemplares similares
-
Diagnostic and economic value of carcinoembryonic antigen, carbohydrate antigen 19-9, and carbohydrate antigen 72-4 in gastrointestinal cancers
por: Liu, Hai-Ning, et al.
Publicado: (2023) -
Prognostic value of lymph nodes count on survival of patients with distal cholangiocarcinomas
por: Lin, Hua-Peng, et al.
Publicado: (2018) -
Carcinoembryonic antigen, carbohydrate antigen 199 and carbohydrate antigen 724 in gastric cancer and their relationship with clinical prognosis
por: Wang, Ran, et al.
Publicado: (2023) -
Diagnostic value of elevated serum carbohydrate antigen 125 level in sarcoidosis
por: Zhang, Qian, et al.
Publicado: (2022) -
Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer
por: Balaban, Daniel Vasile, et al.
Publicado: (2022)